Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $0.6750, but opened at $0.6346. Elite Pharmaceuticals shares last traded at $0.6076, with a volume of 766,318 shares.
Elite Pharmaceuticals Trading Down 3.1%
The stock has a market capitalization of $605.06 million, a PE ratio of -56.36 and a beta of 0.10. The company has a current ratio of 7.23, a quick ratio of 5.44 and a debt-to-equity ratio of 0.09. The business’s 50-day moving average is $0.63 and its two-hundred day moving average is $0.60.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Articles
- Five stocks we like better than Elite Pharmaceuticals
- Top Stocks Investing in 5G Technology
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- What Makes a Stock a Good Dividend Stock?
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- Differences Between Momentum Investing and Long Term Investing
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
